Prenetics Global

Bitcoin Treasury And Global Longevity Demand Will Drive Future Health Platform Expansion

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

15 Dec 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

202.4%

7.0%

202.4%

7.0%

You can edit this narrative until Dec 16 3:10 PM. Then, changes will post as Updates.

Author's Valuation

US$3146.6% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

US$31

46.6% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

69.83%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.34%

Calculation

US$196.45m

Earnings '28

3.29x

PE Ratio '28

US$645.50m

Market Cap '28

US$645.50m

Market Cap '28

16.84m

No. shares '28

US$38.34

Share Price '28

US$38.34 Share Price '28

Discounted to 2025 @ 7.34% p.a.

US$31.00

Fair Value '25